Paper Review Records
全部论文审稿周期
15 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
121
天
Curculigoside suppresses glioblastoma progression through the EGFR/MMP2 axis: evidence from network pharmacology and experimental validation
作者
Jiawen Han; Zhanchuan Ma; Shan Lin; Wei Wu展开收起
作者单位
Central Laboratory, The First Hospital of Jilin University, Changchun, Jilin 130031, China; Key Laboratory of Organ Regeneration and Transplantation Ministry of Education, Changchun, Jilin 130021, China; Department of Respiratory Medicine, The First Hospital of Jilin University, Changchun, Jilin 130031, China; Department of Neurovascular Surgery, The First Hospital of Jilin University, Changchun, Jilin 130021, China展开收起
122
天
Discovery of Emodin as a novel competitive KPC-2 inhibitor through virtual screening: Synergistic efficacy with Meropenem against Carbapenem-resistant Klebsiella pneumoniae infection
作者
Yan Wang; Jiamin Geng; Bingyan Li; Xuming Deng; Jiaxi Wang; Na Guo展开收起
作者单位
College of Food Science and Engineering, Jilin University, Changchun 130062, China; State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, Institute of Zoonosis, and College of Veterinary Medicine, Jilin University, Changchun 130062, China展开收起
62
天
A honokiol-derived cationic amphiphilic compound combats methicillin-resistant Staphylococcus aureus by disrupting membrane phospholipid homeostasis
作者
Muchen Zhang; Yan Wang; Jing Pan; Shengnan Xu; Shangshang Qin; Yanjiang Shao; Yong Guo展开收起
作者单位
School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, Henan, China; School of Computer Science and Artificial Intelligence, Zhengzhou University, Zhengzhou, Henan 450001, China; Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science, Hengyang Medical School, University of South China, Hengyang 421001, China展开收起
48
天
Synthesis, multi-target enzyme inhibition, and in silico evaluation of phthalimide derivatives with relevance to tuberculosis-associated pathophysiology
作者
Aneela Khushal; Sara Khan; Umar Farooq; Muhammad Naseem Khan; Misbah Hafeez; Rizwana Sarwar展开收起
作者单位
Department of Chemistry, COMSATS University Islamabad, Abbottabad Campus, KPK, Pakistan; Department of Chemistry, Pennsylvania State University, University Park 16802, PA, USA展开收起
67
天
Dual-response mitochondria-targeted fluorescent probe for Hypochlorous acid and viscosity: Applications in liver injury diagnosis and environmental monitoring
作者
Peng Hou; Qi Zhang; Junqiang Liu; Haoqing Ren; Pengfei Qi; Huiling Hou; Song Chen展开收起
作者单位
College of Pharmacy, Qiqihar Medical University, Qiqihar 161006 , PR China; Achievement Transformation Center, Qiqihar Medical University, Qiqihar 161006, PR China展开收起
200
天
Structure-based optimization, in vitro profiling, and ADMET prediction of Celastrol derivatives as potent prolyl endopeptidase inhibitors
作者
Tian-Ge Wang; Jing Zhang; Chang Dai; Wei-Ran Huang; Xiao-Lei Zhu; Kun-Jie Bian; Xian-Ting Jiao; Xing-Kai Qian; Li-Wei Zou展开收起
作者单位
Department of Pediatric infectious, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China; Translational Medicine Research Center, Guizhou Medical University, 550025 Guiyang, Guizhou, China; Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China; Anshan Teachers Training Institute, Anshan 114000, China展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天